Press Release

FDA Grants RMAT Designation to GNSC-001 for Knee Osteoarthritis, Signaling Potential Breakthrough in Treatment

FDA Grants RMAT Designation to GNSC-001 for Knee Osteoarthritis, Signaling Potential Breakthrough...

Jul 17, 2025

The U.S. Food and Drug Administration (FDA) has granted the Regenerative Medicine Advanced Therapy (RMAT) designation to GNSC-001, a pioneering...

Read More →
TBC Uzbekistan Named Among Global Fintech Leaders by CNBC and Statista

TBC Uzbekistan Named Among Global Fintech Leaders by CNBC and Statista

Jul 16, 2025

TBC Uzbekistan has been acknowledged as one of the world’s leading fintech companies in the neobanking category by CNBC and...

Read More →
Modified Herpes Virus Shows Promise in Treating Advanced Melanoma

Modified Herpes Virus Shows Promise in Treating Advanced Melanoma

Jul 16, 2025

A study conducted by researchers from the University of Southern California’s Keck Medicine of USC has revealed that the herpes...

Read More →
Modified Herpes Virus Shows Promise in Treating Advanced Melanoma

Modified Herpes Virus Shows Promise in Treating Advanced Melanoma

Jul 16, 2025

A study conducted by researchers from the University of Southern California’s Keck Medicine of USC has revealed that the herpes...

Read More →
Modified Herpes Virus Shows Promise in Treating Advanced Melanoma

Modified Herpes Virus Shows Promise in Treating Advanced Melanoma

Jul 16, 2025

A study conducted by researchers from the University of Southern California’s Keck Medicine of USC has revealed that the herpes...

Read More →
NanoViricides, Inc. Advances MPox Treatment Amid WHO’s Extended Global Health Emergency

NanoViricides, Inc. Advances MPox Treatment Amid WHO’s Extended Global Health Emergency

Jul 16, 2025

NanoViricides, Inc. (NYSE American: NNVC), a leader in the development of host-mimetic nanomedicine, has reaffirmed its commitment to combating the...

Read More →
NanoViricides, Inc. Advances MPox Treatment Amid WHO’s Extended Global Health Emergency

NanoViricides, Inc. Advances MPox Treatment Amid WHO’s Extended Global Health Emergency

Jul 16, 2025

NanoViricides, Inc. (NYSE American: NNVC), a leader in the development of host-mimetic nanomedicine, has reaffirmed its commitment to combating the...

Read More →
NanoViricides, Inc. Advances MPox Treatment Amid WHO’s Extended Global Health Emergency

NanoViricides, Inc. Advances MPox Treatment Amid WHO’s Extended Global Health Emergency

Jul 16, 2025

NanoViricides, Inc. (NYSE American: NNVC), a leader in the development of host-mimetic nanomedicine, has reaffirmed its commitment to combating the...

Read More →
Dot Ai Introduces ZiM Bridge for Automated Supply Chain Management

Dot Ai Introduces ZiM Bridge for Automated Supply Chain Management

Jul 16, 2025

Dot Ai, a Nasdaq-listed IoT and AI-based SaaS startup, has announced the limited availability of its ZiM Bridge, a device...

Read More →
Dot Ai Introduces ZiM Bridge for Automated Supply Chain Management

Dot Ai Introduces ZiM Bridge for Automated Supply Chain Management

Jul 16, 2025

Dot Ai, a Nasdaq-listed IoT and AI-based SaaS startup, has announced the limited availability of its ZiM Bridge, a device...

Read More →